Sheaff Brock Investment Advisors LLC Reduces Stock Holdings in Humana Inc. (NYSE:HUM)

Sheaff Brock Investment Advisors LLC lowered its holdings in shares of Humana Inc. (NYSE:HUM) by 43.9% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 950 shares of the insurance provider’s stock after selling 743 shares during the quarter. Sheaff Brock Investment Advisors LLC’s holdings in Humana were worth $301,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in HUM. Pzena Investment Management LLC grew its holdings in Humana by 538.7% during the second quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock valued at $866,250,000 after purchasing an additional 1,955,375 shares during the period. Ontario Teachers Pension Plan Board increased its holdings in Humana by 11,647.2% in the 1st quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider’s stock worth $367,342,000 after acquiring an additional 1,050,459 shares in the last quarter. Marshall Wace LLP lifted its holdings in Humana by 118.9% during the second quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock valued at $532,564,000 after purchasing an additional 774,085 shares in the last quarter. International Assets Investment Management LLC boosted its position in shares of Humana by 261,025.1% in the third quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock worth $2,340,660,000 after purchasing an additional 738,701 shares during the period. Finally, Steadfast Capital Management LP purchased a new stake in shares of Humana in the first quarter worth $158,813,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Trading Down 2.6 %

HUM opened at $275.67 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The firm has a market cap of $33.19 billion, a price-to-earnings ratio of 24.42, a PEG ratio of 2.29 and a beta of 0.52. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $527.18. The stock has a fifty day moving average price of $281.36 and a 200-day moving average price of $331.61.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping the consensus estimate of $3.48 by $0.68. The firm had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. As a group, equities research analysts anticipate that Humana Inc. will post 15.83 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.28%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio is presently 31.36%.

Analyst Ratings Changes

HUM has been the subject of several recent analyst reports. Jefferies Financial Group downgraded Humana from a “buy” rating to a “hold” rating and dropped their price target for the stock from $519.00 to $253.00 in a research note on Monday, October 7th. Wells Fargo & Company cut their target price on shares of Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research note on Monday, November 4th. JPMorgan Chase & Co. boosted their price target on shares of Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 21st. Sanford C. Bernstein upgraded Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price objective for the company in a research report on Tuesday, October 8th. Finally, KeyCorp started coverage on Humana in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. Twenty research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $315.86.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.